India Health Ministry Pushes For Tougher Regulation Of Clinical Trials
This article was originally published in PharmAsia News
India’s government is seeking broad authority to regulate all forms of clinical drug trials by the end of this year, with stringent punishment for violators, an outgrowth of recent trials on children with learning disabilities.
You may also be interested in...
Non-profit approach is reassuring for healthcare payers, but vaccines won’t be ready to stop pandemic at its peak.
Executives On The Move: BMS Taps Barclays Exec For Strategy Spot, Epizyme Selects Science Chief And A Board Election At ADC Therapeutics
Bristol-Myers Squibb taps Barclays chair of global life sciences as it EVP, strategy and business development, and cancer therapeutics firm Epizyme Inc. selects a chief scientific officer. At ADC Therapeutics, an oncology drug development company, a new chairman is elected.